Arteris, Inc. (AIP) AI Stock Analysis

Arteris, Inc. specializes in providing semiconductor interconnect intellectual property (IP) and deployment solutions across global markets including the Americas, Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports on-chip interconnect fabric technology crucial for System-on-Chip (SoC) designs and Network-on-Chip (NoC) interconnect IP. Key offerings include FlexNoC, FlexWay, Ncore cache-coherent interconnect IP, and CodaCache. Arteris also provides IP deployment solutions such as Magillem Connectivity, Magillem Registers, CSRCompiler, and Harmony Trace to semiconductor manufacturers, OEMs, and electronic system producers.

Arteris expanded annual revenue from $37.9M in FY2021 to $50.4M in FY2022, $53.7M in FY2023, $57.7M in FY2024, and $70.6M in FY2025, reflecting a 5-year revenue CAGR of 17.3%. Gross margin remained consistently high at 90.1% in FY2021, 91.5% in FY2022, 90.5% in FY2023, 89.7% in FY2024, and 90.2% in FY2025. Despite revenue growth of 22.3% in FY2025, the company reported an operating margin of -47.0% and a net loss of -$34.7M. Over the trailing twelve months ended June 30, 2026, revenue reached $84.6M, with quarterly revenue growth of 46.2% year-over-year and an EPS of -$0.87.

As of June 30, 2026, Arteris held $122.1M in cash and short-term investments against total debt of $8.7M, resulting in net cash of $113.4M. Shareholders' equity was $67.7M and total assets were $224.7M, yielding a current ratio of 1.57 and a debt-to-equity ratio of 0.13. For FY2025, operating cash flow turned positive at $6.7M, supporting free cash flow of $5.3M after capital expenditures of $1.4M.

Arteris trades at a price-to-sales ratio of 10.9x and an EV to revenue multiple of 12.7x, both at a premium to the median of its US-listed Technology peers at 2.8x sales. Its forward P/E ratio is 172.4x, compared to 18.8x for the peer group median. Over the past year, AIP shares gained 33.0%, outperforming the S&P 500 return of 16.8%. The stock traded at $18.76 on October 16, 2026, which is -24.6% relative to its 200-day average.

Wall Street coverage consists of 7 Strong Buy ratings and 0 Buy, Hold, Sell, or Strong Sell ratings. The mean price target of $39.43 implies an upside of 110.2% over the last close of $18.76. For the current fiscal year ending December 31, 2026, analysts estimate an EPS of -$0.18 on revenue of $96.7M. For the next fiscal year, 7 analysts project EPS of $0.12 and revenue of $117.0M. Arteris beat EPS estimates in 1 of the last 4 quarters, with next earnings scheduled for November 3, 2026.

This page is an AI-written research summary of Arteris, Inc. (AIP). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: AIP income statement, AIP balance sheet, AIP key metrics, AIP analyst forecast, AIP chart. See the AIP stock overview for the latest quote and news.